Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Read the new ERS statement on familial pulmonary fibrosis here

  • An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants
    PAH due to SOX17 variants is a severe phenotype associated with CHD, haemoptysis and radiological anomalies. Histopathology shows severe pulmonary arterial remodelling and malformations affecting pulmonary vessels and systemic arteries.
  • ERJ latest issue: Editor's highlights
    Click through for a list of highlighted articles published in the latest complete issue of the European Respiratory Journal, as selected by Chief Editor James D. Chalmers and Deputy Chief Editor Don D. Sin
  • Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis
    This study published in the ERJ shows that ortezomib-mediated depletion of plasma cells but not anti-CD20-mediated B-cell depletion inhibits bleomycin-induced lung fibrosis, suggesting that plasma cells may be a therapeutic target for IPF
  • Open access journals from ERS
    ERS publishes three open access journals and can satisfy most funder mandates. Explore ERJ Open Research, the European Respiratory Review and Breathe using the dropdown above.
  • 1
  • 2
  • 3
  • 4

The European Respiratory Journal – current impact factor 33.8 – is the flagship journal of the European Respiratory Society. 

The ERJ publishes clinical and experimental work relating to all aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine and thoracic surgery. In addition to original research material, the ERJ also publishes editorial commentaries, reviews, short research letters and correspondence to the editor. Articles are published continuously and collected into 12 monthly issues in two volumes per year.

For more information, please refer to our instructions for authors
Manuscripts can be submitted through our online submission platform

Read the current issue

Latest Articles

  • Development of a tool to detect small airways dysfunction in asthma clinical practice
    Janwillem Kocks, Thys van der Molen, Jaco Voorham, Simonetta Baldi, Maarten van den Berge, Chris Brightling, Leonardo M. Fabbri, Monica Kraft, Gabriele Nicolini, Alberto Papi, Klaus F. Rabe, Salman Siddiqui, Dave Singh, Judith Vonk, Marika Leving, Bertine Flokstra-de Blok
    European Respiratory Journal Mar 2023, 61 (3) 2200558; DOI: 10.1183/13993003.00558-2022
  • If your patient with asthma wheezes when sitting or lying quietly, lung function testing may reveal small airway disease
    Peter B. Noble, Graham M. Donovan
    European Respiratory Journal Mar 2023, 61 (3) 2202307; DOI: 10.1183/13993003.02307-2022
  • Hiding in plain sight: the evolving definition of chronic breathlessness and new ICD-11 wording
    Slavica Kochovska, Magnus Ekström, John Hansen-Flaschen, Diana Ferreira, Thomas Similowski, Miriam J. Johnson, David C. Currow
    European Respiratory Journal Mar 2023, 61 (3) 2300252; DOI: 10.1183/13993003.00252-2023
  • “Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor–ivacaftor in people with cystic fibrosis.” A. Campredon, E. Battistella, C. Martin, et al. Eur Respir J 2022; 59: 2101344.
    European Respiratory Journal Mar 2023, 61 (3) 2151344; DOI: 10.1183/13993003.51344-2021
  • Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond
    Jonathan Corren, Christopher E. Brightling, Louis-Philippe Boulet, Celeste Porsbjerg, Michael E. Wechsler, Andrew Menzies-Gow, Christopher S. Ambrose, Bill Cook, Neil Martin, Joseph Spahn, Jean-Pierre Llanos
    European Respiratory Journal Mar 2023, 61 (3) 2202202; DOI: 10.1183/13993003.02202-2022
  • Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
    Marc Miravitlles, Alice M. Turner, María Torres-Duran, Hanan Tanash, Carlota Rodríguez-García, José Luis López-Campos, Jan Chlumsky, Catarina Guimaraes, Juan Luis Rodríguez-Hermosa, Angelo Corsico, Cristina Martinez-González, José María Hernández-Pérez, Ana Bustamante, David G. Parr, Francisco Casas-Maldonado, Ana Hecimovic, Wim Janssens, Beatriz Lara, Miriam Barrecheguren, Cruz González, Jan Stolk, Cristina Esquinas, Christian F. Clarenbach
    European Respiratory Journal Mar 2023, 61 (3) 2201949; DOI: 10.1183/13993003.01949-2022
Back to top

ABOUT THE ​ERJ

  • Journal information
  • Editorial board
  • Continuing medical education

 

COPE Member since 2009 JM04643
Web of Science Group ALPSP

 

  • Most Read
  • Twitter
Loading
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • European Respiratory Society guidelines for the diagnosis of asthma in adults
  • ERS clinical practice guidelines on treatment of sarcoidosis
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society